echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Bulletin on November 11, 2021: The overall global epidemic situation continues to rise; the new crown mRNA vaccine is effective as a booster, and the domestic mRNA vaccine has begun to boost clinical trials

    Bulletin on November 11, 2021: The overall global epidemic situation continues to rise; the new crown mRNA vaccine is effective as a booster, and the domestic mRNA vaccine has begun to boost clinical trials

    • Last Update: 2021-12-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    As of 8:01 on November 11, 2021, Beijing time, Worldometers world real-time statistics show that the cumulative number of confirmed new coronary pneumonia ( COVID-19 ) cases worldwide has exceeded 252.
    06 million, with an increase of 502,254 cases, reaching 252,066,500
    .


    The total number of deaths reached 5.


    New Coronary Pneumonia COVID-19 Briefing on November 10, 2021: The United Kingdom and the United States are fully open to international travel, and the Chinese vaccine is approved; France requires people over 65 to receive the third dose of the new coronavirus vaccine; Israel’s intensive injection has brought the epidemic under control again

    Denmark "lying flat" two months later, the number of cases surged, plans to restart the new crown passport

    Denmark "lying flat" two months later, the number of cases surged, plans to restart the new crown passport

    According to the European media "The Local" (The Local) Danish version reported on November 10, the Danish Parliament has agreed that the government will re-introduce the epidemic restriction measures, including the "new crown passport" (coronapas), on the 12th, and at the same time, once again raise the alert level of the epidemic.
    Elevated to the "serious threat" stage
    .

    According to a report on the 10th in the local newspaper, the majority of members of the Danish Parliament’s Epidemic Committee, including left-wing and right-wing parties, supported the government’s position and re-introduced the “new crown passport” from November 12
    .


    At the same time, this "new crown passport" also lowered the age limit from 16 to over 15 years old


    At that time, anyone who goes to bars, restaurants, cafes, nightclubs, and other indoor places that provide beverages and food must provide a "new crown passport" to the store to prove that they have been vaccinated, have recovered from the infection , or within a period of time Negative nucleic acid results
    .

    Infect

    In addition, for indoor competitions with more than 200 spectators and outdoor competitions with more than 2,000 spectators, the spectators must also show their "new crown passports
    .


    " These venues include amusement parks, casinos, adventure and water parks, concerts, conferences and lecture venues


    In the four Nordic countries, the vaccination situation is inversely proportional to the epidemic situation

    In the four Nordic countries, the vaccination situation is inversely proportional to the epidemic situation

    More than 85% of the population over the age of 16 in Sweden have received at least one dose of the new crown vaccine, and the epidemic is now relatively flat
    .

    However, Swedish experts reminded that, in fact, the country has already begun to see a new increase in cases: in the last two weeks of October, the 14-day incidence rate was 107 new infections per 100,000 people, compared with 89 cases in the previous two weeks
    .


    In addition, the vaccination rates of different age groups are also different.


    Curve of 7-day average number of newly confirmed cases in the four Nordic countries (from top to bottom: Denmark, Norway, Finland, Sweden)

    Vaccination status in major European countries

    It is worth mentioning that the situation in Norway, which first took measures to restrict the entry of tourists from neighboring countries, is not optimistic
    .


    According to the statistics of "Viewing the World from Data", like Denmark, the number of new confirmed cases in Norway began to surge two weeks after October.


    Finland is closely followed, and data shows that the number of new diagnoses in Finland also showed an increasing trend at the end of October
    .


    According to the Schengen visa website, the Finnish government has decided to extend travel restrictions for travelers from countries outside the European Union, that is, travelers who have not completed the vaccination are not allowed to enter the country


    At present, the infection rate is still rising in 55 countries
    .


    Especially in Europe, data shows that this region has once again become the "epicenter" of the new crown epidemic, and more than half of the world's new confirmed cases are from European countries


    According to data from the European Center for Disease Control and Prevention (ECDC), the current epidemic in Eastern European countries and Russia is very serious, and people there are fighting the rising number of confirmed cases and deaths
    .


    Among them, most of the deaths have not received the new crown vaccine, and the vaccination rate there is only about 24%


    The new round of the epidemic has caused the Nordic countries to "brother the wall" again.
    Denmark's neighbor, Norway, has announced restrictions on the entry of tourists from neighboring countries
    .
    Not only the Nordic countries, but Europe has become the "epicenter" of a new round of epidemics
    .
    The latest data from Germany on the 10th showed that there were nearly 40,000 new cases in a single day in Germany, the highest record since the outbreak of the new crown epidemic
    .

    Which new anti-"new crown" drug has a better effect? Oral drugs will squeeze the development of neutralizing antibodies

    Which new anti-"new crown" drug has a better effect? Oral drugs will squeeze the development of neutralizing antibodies

    The new crown mRNA vaccine will be used as a booster for Phase III clinical trials

    The new crown mRNA vaccine will be used as a booster for Phase III clinical trials

    According to the announcement on the 8th by the government service platform of the Ministry of Science and Technology, the IIIb clinical trial of the new crown mRNA vaccine as an enhanced needle has been approved by the Ministry of Science and Technology
    .
    At present, domestic manufacturers of COVID-19 mRNA vaccines include: Abbe Biotech, Watson Biotech, and Si Microbiology
    .
    Watson Bio told the reporter of "Science Innovation Board Daily" that the information published by the Ministry of Science and Technology of the People's Republic of China shall prevail
    .

    Zhengzhou City will start a new round of nucleic acid testing for all employees on the 11th

    Zhengzhou City will launch a new round of nucleic acid testing for all employees on the 11th Zhengzhou City will launch a new round of nucleic acid testing for all employees on the 11th

    It was learned from the press conference of the Zhengzhou Municipal Government that Zhengzhou City insisted on continuous rolling inspections of “one inspection per day” for key areas and key populations.
    Among them, Xingyang City and Xinmi City have conducted two rounds of other areas outside the control area.
    Nucleic acid test for all employees, the test results were all negative
    .
    While insisting on conducting nucleic acid testing for key personnel and key areas, Zhengzhou City launched the first round of nucleic acid testing for all employees in Jinshui District, Erqi District, Zhongyuan District, Guancheng District, Zhengdong New District, and High-tech Zone on November 8.
    A total of more than 6.
    98 million people were tested and the results were all negative
    .
    Tomorrow (11th) Zhengzhou City will start the second round of nucleic acid testing for all employees
    .

    German health department recommends suspension of Modena vaccination for people under 30

    The German health department recommends a suspension of vaccination of Modena for people under 30

    The German health department announced on the 10th local time that although studies have shown that vaccination of Modena vaccine may cause a small risk of heart inflammation, the health department still recommends that young people under 30 years of age suspend vaccination of Modena vaccine
    .

    France: Only when people over 65 get the new crown vaccine booster injection can "renew their license"

    France: Only when people over 65 years old get the new crown vaccine booster can "renew their license" France: Only people over 65 years old get the new crown vaccine booster shot to "renew their certificate"

    On the 10th local time, French government spokesman Adal said that elderly people over 65 years old need to receive the third shot within six months and five weeks after the second shot of the new crown vaccine, otherwise their health pass will become invalid
    .
    On the 9th, French President Macron stated that elderly people over 65 need to receive a third dose of the new crown vaccine in order to extend the validity period of their health passes
    .

    Malaysia will begin to vaccinate all citizens aged 40 and above with the new crown vaccination booster

    Malaysia will begin to vaccinate all citizens aged 40 and above with the new crown vaccination booster

    On the 11th local time, Malaysian Minister of Health Hairi announced that the Malaysian government will vaccinate all citizens aged 40 and above with the new crown vaccine booster
    .
    He said that the measure is carried out under the Malaysian National New Crown Vaccine Program, and priority is given to people 40 years of age and older with comorbidities to be vaccinated
    .
    Hajri said the move will enhance the people on the new crown pneumonia immunity , and enhance the protective effect
    .

    immunity

    mRNA vaccine as a booster, excellent performance

    mRNA vaccine as a booster, excellent performance

    The new crown mRNA vaccine has shown superior effects in preventing new crown infection in both clinical research and post-marketing practice.
    After the basic immunization of the inactivated vaccine is completed, the mRNA vaccine is used for heterologous sequential strengthening to enhance the immune response, and it has been increasingly received by professionals.
    Explore
    .

    prevention

    A Turkish real-world study published online in the Journal of Medical Virology on September 18 this year showed that compared with the third dose of inactivated vaccine homologous booster immunization, the BNT162b2 mRNA vaccine was used after the completion of two doses of inactivated vaccine.
    The IgG antibody level induced by sequential booster vaccination was 27 times that of the former
    .

    Experts indicate that this effect may not only come from the powerful immune response of the mRNA vaccine itself, but also from the potential synergistic complementarity between vaccines of different technical routes
    .

    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.